Arabinogalactan in Clinical Use

  • Rajendra P. Pawar
  • , Babasaheb A. Kushekar
  • , Bhaskar S. Jadhav
  • , Kiran R. Kharat
  • , Ravikumar M. Borade
  • , Abraham J. Domb

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

9 Scopus citations
Original languageEnglish
Title of host publicationBiodegradable Polymers in Clinical Use and Clinical Development
PublisherJohn Wiley and Sons
Pages217-245
Number of pages29
ISBN (Print)9780470424759
DOIs
StatePublished - 3 May 2011
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Arabinogalactan biosynthesis in mycobateria tuberculosis - three steps
  • Arabinogalactan in clinical use, biologically active arabinogalactan - isolated from roots of Angelica acutiloba
  • Natural killer (NK) cytotoxicity, and human NK cytotoxicity - "the ability of spontaneous cytotoxicity against tumor and virus-infected cells"

Cite this